Back to Gene
DMD gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

DMD gene

The DMD gene is the largest known human gene and provides instructions for making dystrophin, a protein critical for maintaining the structural integrity of muscle fibers.

Normal Function

DMD, the largest known human gene, provides instructions for making a protein called dystrophin. This protein is located primarily in muscles used for movement (skeletal muscles) and in heart (cardiac) muscle. Small amounts of dystrophin are also present in nerve cells in the brain.

In skeletal and cardiac muscles, dystrophin is part of a protein complex that strengthens muscle fibers and protects them from injury during contraction and relaxation. The dystrophin complex acts as an anchor, connecting each muscle cell's structural framework (cytoskeleton) with the lattice of proteins and other molecules outside the cell (extracellular matrix). The complex may also play a role in cell signaling. In nerve cells, research suggests dystrophin is important for the normal structure and function of synapses.

Health Conditions Related to Genetic Changes

Duchenne and Becker muscular dystrophy

More than 2,000 mutations in the DMD gene have been identified in people with the Duchenne and Becker forms of muscular dystrophy. These conditions occur almost exclusively in males and are characterized by progressive muscle weakness, wasting (atrophy), and a heart condition called dilated cardiomyopathy.

  • Becker muscular dystrophy: Mutations typically lead to an abnormal version of dystrophin that retains some function, resulting in milder features that appear at a later age.
  • Duchenne muscular dystrophy: Mutations typically prevent any functional dystrophin from being produced, leading to more severe symptoms.

Skeletal and cardiac muscle cells without enough functional dystrophin become damaged as muscles contract and relax. Over time, these cells weaken and die, causing the characteristic muscle weakness and heart problems.

X-linked dilated cardiomyopathy

More than 30 mutations in the DMD gene can cause an X-linked form of familial dilated cardiomyopathy. This condition enlarges and weakens the cardiac muscle, preventing the heart from pumping blood efficiently. Unlike Duchenne and Becker muscular dystrophy, this condition is typically not associated with the weakness and wasting of skeletal muscles.

These mutations preferentially affect the activity of dystrophin in cardiac muscle cells. Affected individuals typically have little or no functional dystrophin in the heart, leading to damaged cardiac muscle cells that weaken and die over time.

Other Names for This Gene

  • BMD
  • DMD_HUMAN
  • dystrophin (muscular dystrophy, Duchenne and Becker types)

Genomic Location

The DMD gene is found on the X chromosome.

Frequently Asked Questions

Routine cardiac evaluation every 6–12 months with echocardiography and ECG is recommended. Early use of ACE inhibitors or beta‑blockers can slow the progression of dilated cardiomyopathy, and newer therapies like corticosteroids may also provide cardiac benefits.
Early diagnosis is possible in infancy or early childhood, often before symptoms appear, using a combination of elevated creatine kinase levels, muscle biopsy, and DNA testing for DMD gene mutations. Newborn screening panels in some regions also include DMD testing.
Common early signs include difficulty running or jumping, frequent falls, calf muscle enlargement (pseudohypertrophy), and a waddling gait. These symptoms usually emerge between ages 2 and 5.
Standard care includes corticosteroids (prednisone or deflazacort) to preserve muscle strength, physical therapy to maintain mobility, and respiratory support as needed. Emerging treatments such as exon‑skipping drugs (e.g., eteplirsen) and gene‑replacement therapies are approved for specific mutations and are being expanded through clinical trials.///
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab